TY - JOUR
T1 - Neural Responses to Fluoxetine in Youths with Disruptive Behavior and Trauma Exposure
T2 - A Pilot Study
AU - Hwang, Soonjo
AU - Chung, Unsun
AU - Chang, Yongmin
AU - Kim, Eunji
AU - Suk, Ji Woo
AU - Meffert, Harma
AU - Kratochvil, Christopher
AU - Leibenluft, Ellen
AU - Blair, James
N1 - Funding Information:
1Department of Psychiatry, University of Nebraska Medical Center, Omaha, Nebraska, USA. 2Department of Psychiatry and Department of Radiology, Kyoungbook National University Hospital, Daegu, Republic of Korea. 3Target Holding, Groningen, The Netherlands. 4Emotion and Development Branch, National Institute of Mental Health, Bethesda, Maryland, USA. 5Center for Neurobehavioral Research, Boys Town National Research Hospital, Boys Town, Nebraska, USA. iORCID ID (https://orcid.org/0000-0001-5117-2468). iiORCID ID (https://orcid.org/0000-0002-6377-2361). Funding: This work was supported by the National Institute of Mental Health U01MH120155-01A1 and the Ministry of Education of the Republic of Korea.
Publisher Copyright:
© Soonjo Hwang et al. 2021; Published by Mary Ann Liebert, Inc. 2021.
PY - 2021/10
Y1 - 2021/10
N2 - Objective: A preliminary investigation of the impact of a serotonergic agent (fluoxetine) on symptom profile and neural response in youths with disruptive behavior disorders (DBDs) and a history of trauma exposure. Methods: There were three participant groups: (i) Youths with DBDs and trauma exposure who received fluoxetine treatment for 8 weeks (n = 11); (ii) A matched group of youths with DBDs and trauma exposure who received routine regular follow-up in an outpatient clinic (n = 10); and (iii) Typically developing youths (n = 18). All participants conducted an expression processing functional magnetic resonance imaging task twice, 8 weeks apart: (pretreatment and post-Treatment for youths with DBDs). Results: Youths with DBDs and trauma exposure who received fluoxetine treatment compared to the other two groups showed: (i) significant improvement in externalizing, oppositional defiant disorder, irritability, anxiety-depression, and trauma-related symptoms; (ii) as a function of fearful expression intensity, significantly decreased amygdala response and increased recruitment of regions implicated in top-down attention control (insula cortex, inferior parietal lobule, and postcentral gyrus) and emotional regulation (ventromedial prefrontal cortex [vmPFC]); and (iii) correlation between DBD/irritability symptom improvement and increased activation of top-down attention control areas (inferior parietal lobule, insula cortex, and postcentral gyrus) and an emotion regulation area (vmPFC). Conclusions: This study provides preliminary evidence that a serotonergic agent (fluoxetine) can reduce disruptive behavior and mood symptoms in youths with DBDs and trauma exposure and that this may be mediated by enhanced activation of top-down attention control and emotion regulation areas (inferior parietal lobule, insula cortex, and vmPFC).
AB - Objective: A preliminary investigation of the impact of a serotonergic agent (fluoxetine) on symptom profile and neural response in youths with disruptive behavior disorders (DBDs) and a history of trauma exposure. Methods: There were three participant groups: (i) Youths with DBDs and trauma exposure who received fluoxetine treatment for 8 weeks (n = 11); (ii) A matched group of youths with DBDs and trauma exposure who received routine regular follow-up in an outpatient clinic (n = 10); and (iii) Typically developing youths (n = 18). All participants conducted an expression processing functional magnetic resonance imaging task twice, 8 weeks apart: (pretreatment and post-Treatment for youths with DBDs). Results: Youths with DBDs and trauma exposure who received fluoxetine treatment compared to the other two groups showed: (i) significant improvement in externalizing, oppositional defiant disorder, irritability, anxiety-depression, and trauma-related symptoms; (ii) as a function of fearful expression intensity, significantly decreased amygdala response and increased recruitment of regions implicated in top-down attention control (insula cortex, inferior parietal lobule, and postcentral gyrus) and emotional regulation (ventromedial prefrontal cortex [vmPFC]); and (iii) correlation between DBD/irritability symptom improvement and increased activation of top-down attention control areas (inferior parietal lobule, insula cortex, and postcentral gyrus) and an emotion regulation area (vmPFC). Conclusions: This study provides preliminary evidence that a serotonergic agent (fluoxetine) can reduce disruptive behavior and mood symptoms in youths with DBDs and trauma exposure and that this may be mediated by enhanced activation of top-down attention control and emotion regulation areas (inferior parietal lobule, insula cortex, and vmPFC).
KW - disruptive behavior disorder
KW - fluoxetine
KW - insula
KW - trauma
KW - ventromedial prefrontal cortex
UR - http://www.scopus.com/inward/record.url?scp=85118171973&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118171973&partnerID=8YFLogxK
U2 - 10.1089/cap.2020.0174
DO - 10.1089/cap.2020.0174
M3 - Article
C2 - 34076503
AN - SCOPUS:85118171973
SN - 1044-5463
VL - 31
SP - 562
EP - 571
JO - Journal of Child and Adolescent Psychopharmacology
JF - Journal of Child and Adolescent Psychopharmacology
IS - 8
ER -